Navigation Links
Scientists take cancer research back to the basic molecular level
Date:9/15/2008

PHILADELPHIA Scientists and clinicians from around the world will gather in Philadelphia, Pennsylvania, next week at the American Association for Cancer Research's third International Conference on Molecular Diagnostics in Therapeutic Development.

The conference is subtitled, "Fulfilling the Promise of Personalized Medicine," which reflects the potential of molecular diagnostics to provide new strategies for tailoring therapies to fit the needs of each cancer patient's unique biology.

Sessions will include discussions on the use of biomarkers in clinical practice and new drug development, advanced imaging technologies for diagnosis, and the application of proteomics in personalized medicine.

Novel findings to be reported at the conference include:

  • A new gene expression analysis that shows important differences in brain cancer.
  • A groundbreaking method of measuring changes in DNA .
  • A new biomarker that could more accurately determine the prognosis of patients with head and neck carcinoma.
  • A more complete and accurate test for blood disorders.

"As genetic, proteomic, imaging and other new technologies have become more sophisticated and our knowledge of tumor biology and signaling pathways advances, so too does our ability to molecularly characterize individual tumors and identify germ line and somatic determinants of patient prognosis and response," said conference chairperson Gordon B. Mills, M.D., Ph.D., chairman of the Department of Molecular Therapeutics at the University of Texas M. D. Anderson Cancer Center.

"This new era of personalized medicine has brought with it great opportunities to enhance cancer drug development and improve patient care," said Mills. "However, in order to harness this potential and maximize these opportunities, it is essential that there be an ongoing exchange of new ideas and information."

In addition to the symposia and poster sessions, the conference will include two keynote lectures. The first will be from David Sidransky, M.D., director of head and neck cancer research at the Johns Hopkins Hospital, who will deliver, "Personalized Cancer Medicine in the Next Decade." The second will be from Joe W. Gray, Ph.D., director of the Division of Life Sciences at the Lawrence Berkley National Laboratory, who will speak on, "Models of Molecular Diversity to Facilitate Marker Guided Therapy."


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Gina Negrette, a ... more than a decade of experience in psychiatry, treating clients in diverse settings, ... eating disorders, psychotic and manic conditions, as well as those who were fighting ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... for its Product Innovation in the prestigious CEO World Awards®. The coveted annual ... new products and services, CEO case studies, corporate social responsibility, and milestones from ...
(Date:7/24/2017)... ... ... Engineers at the University of Maryland have invented an entirely new kind of ... the body uses. , In ordinary batteries the electrical energy, or current, delivered ... battery is generated by moving positive ions from one end to the other of ...
(Date:7/24/2017)... ... July 24, 2017 , ... Cheerag D. Upadhyaya , M.D., M.Sc., FAANS ... Institute (SLMBNI), part of Saint Luke’s Health System . Dr. Upadhyaya has ... Upadhyaya, MD. M.Sc., FAANS joins Stanley P. Fisher, M.D., who has served ...
(Date:7/24/2017)... CA (PRWEB) , ... July 24, 2017 , ... Cosmetic ... spotlight doctors and the cosmetic surgeries they perform on a daily basis. , ... the cosmetic surgery procedures they specialize in at their practices. , When asked ...
Breaking Medicine News(10 mins):
(Date:7/6/2017)... , July 6, 2017 ThriveRx, the nutrition division of Diplomat ... families to thrive on nutrition support. To celebrate its anniversary, ... site has a fresh new look with improved organization to create the ... ... "We,ve ...
(Date:7/5/2017)... 5, 2017 Pace Analytical, a company of over 2,000 employees and ... have acquired ESC Lab Sciences, further solidifying their position as the top American ... . ... and CEO of Pace Analytical ... out of Mt Juliet, TN , enhances Pace Analytical,s capability ...
(Date:6/30/2017)... 2017 In vitro diagnostics market firm Kalorama ... at least ten diagnostic companies have successfully completed financings.  ... and a loan facility.  The size of these financings ... Kalorama Information provides a monthly IVD Market Trends ... Center. "Diagnostics ...
Breaking Medicine Technology: